Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Data(s) |
01/03/2006
|
---|---|
Identificador |
http://dx.doi.org/10.1007/s00125-006-0160-4 http://www.scopus.com/inward/record.url?scp=33646401140&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Bingley , P J , Gale , E A M , Carson , D & Trial , T E N D I 2006 , ' Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk ' Diabetologia , vol 49(5) , no. 5 , pp. 881-890 . DOI: 10.1007/s00125-006-0160-4 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2712 #Endocrinology, Diabetes and Metabolism #/dk/atira/pure/subjectarea/asjc/2700/2724 #Internal Medicine |
Tipo |
article |